BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 30116543)

  • 1. Effect of Rosuvastatin on Acute Kidney Injury in Sepsis-Associated Acute Respiratory Distress Syndrome.
    Hsu RK; Truwit JD; Matthay MA; Levitt JE; Thompson BT; Liu KD
    Can J Kidney Health Dis; 2018; 5():2054358118789158. PubMed ID: 30116543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of total cholesterol and statin therapy on mortality in ARDS patients: a secondary analysis of the SAILS and HARP-2 trials.
    Pienkos SM; Moore AR; Guan J; Levitt JE; Matthay MA; Baron RM; Conlon J; McAuley DF; O'Kane CM; Rogers AJ
    Crit Care; 2023 Mar; 27(1):126. PubMed ID: 36978134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. One-year outcomes of rosuvastatin versus placebo in sepsis-associated acute respiratory distress syndrome: prospective follow-up of SAILS randomised trial.
    Dinglas VD; Hopkins RO; Wozniak AW; Hough CL; Morris PE; Jackson JC; Mendez-Tellez PA; Bienvenu OJ; Ely EW; Colantuoni E; Needham DM
    Thorax; 2016 May; 71(5):401-10. PubMed ID: 26936876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical predictors of renal non-recovery in acute respiratory distress syndrome.
    Panitchote A; Mehkri O; Hastings A; Hanane T; Demirjian S; Torbic H; Mireles-Cabodevila E; Krishnan S; Duggal A
    BMC Nephrol; 2019 Jul; 20(1):255. PubMed ID: 31291909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Elevated Plasma Interleukin-18 Level With Increased Mortality in a Clinical Trial of Statin Treatment for Acute Respiratory Distress Syndrome.
    Rogers AJ; Guan J; Trtchounian A; Hunninghake GM; Kaimal R; Desai M; Kozikowski LA; DeSouza L; Mogan S; Liu KD; Matthay MA; Steingrub J; Wheeler A; Yoon JH; Nakahira K; Choi AM; Baron RM
    Crit Care Med; 2019 Aug; 47(8):1089-1096. PubMed ID: 31206358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early high-dose rosuvastatin for contrast-induced nephropathy prevention in acute coronary syndrome: Results from the PRATO-ACS Study (Protective Effect of Rosuvastatin and Antiplatelet Therapy On contrast-induced acute kidney injury and myocardial damage in patients with Acute Coronary Syndrome).
    Leoncini M; Toso A; Maioli M; Tropeano F; Villani S; Bellandi F
    J Am Coll Cardiol; 2014 Jan 7-14; 63(1):71-9. PubMed ID: 24076283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Latent class analysis of ARDS subphenotypes: a secondary analysis of the statins for acutely injured lungs from sepsis (SAILS) study.
    Sinha P; Delucchi KL; Thompson BT; McAuley DF; Matthay MA; Calfee CS;
    Intensive Care Med; 2018 Nov; 44(11):1859-1869. PubMed ID: 30291376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Rosuvastatin in Contrast-Induced Acute Kidney Injury in the Elderly: Post Hoc Analysis of the PRATO-ACS Trial.
    Tropeano F; Leoncini M; Toso A; Maioli M; Dabizzi L; Biagini D; Villani S; Bellandi F
    J Cardiovasc Pharmacol Ther; 2016 Mar; 21(2):159-66. PubMed ID: 26307206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluid Overload Precedes and Masks Cryptic Kidney Injury in Pediatric Acute Respiratory Distress Syndrome.
    Dixon CG; Thadani S; Fitzgerald JC; Akcan-Arikan A; Yehya N
    Crit Care Med; 2023 Jun; 51(6):765-774. PubMed ID: 36939256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rosuvastatin for sepsis-associated acute respiratory distress syndrome.
    ; Truwit JD; Bernard GR; Steingrub J; Matthay MA; Liu KD; Albertson TE; Brower RG; Shanholtz C; Rock P; Douglas IS; deBoisblanc BP; Hough CL; Hite RD; Thompson BT
    N Engl J Med; 2014 Jun; 370(23):2191-200. PubMed ID: 24835849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors associated with acute kidney injury in acute respiratory distress syndrome.
    Panitchote A; Mehkri O; Hastings A; Hanane T; Demirjian S; Torbic H; Mireles-Cabodevila E; Krishnan S; Duggal A
    Ann Intensive Care; 2019 Jul; 9(1):74. PubMed ID: 31264042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of a "Specific Population Who Could Benefit From Rosuvastatin": A Secondary Analysis of a Randomized Controlled Trial to Uncover the Novel Value of Rosuvastatin for the Precise Treatment of ARDS.
    Zhang S; Lu Z; Wu Z; Xie J; Yang Y; Qiu H
    Front Med (Lausanne); 2020; 7():598621. PubMed ID: 33335905
    [No Abstract]   [Full Text] [Related]  

  • 13. Short-term rosuvastatin therapy for prevention of contrast-induced acute kidney injury in patients with diabetes and chronic kidney disease.
    Han Y; Zhu G; Han L; Hou F; Huang W; Liu H; Gan J; Jiang T; Li X; Wang W; Ding S; Jia S; Shen W; Wang D; Sun L; Qiu J; Wang X; Li Y; Deng J; Li J; Xu K; Xu B; Mehran R; Huo Y
    J Am Coll Cardiol; 2014 Jan 7-14; 63(1):62-70. PubMed ID: 24076297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiology and Outcomes of Acute Kidney Injury in COVID-19 Patients with Acute Respiratory Distress Syndrome: A Multicenter Retrospective Study.
    Wang F; Ran L; Qian C; Hua J; Luo Z; Ding M; Zhang X; Guo W; Gao S; Gao W; Li C; Liu Z; Li Q; Ronco C
    Blood Purif; 2021; 50(4-5):499-505. PubMed ID: 33291098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between inflammation and benefits of early high-dose rosuvastatin on contrast-induced nephropathy in patients with acute coronary syndrome: the pathophysiological link in the PRATO-ACS study (Protective Effect of Rosuvastatin and Antiplatelet Therapy on Contrast-Induced Nephropathy and Myocardial Damage in Patients With Acute Coronary Syndrome Undergoing Coronary Intervention).
    Toso A; Leoncini M; Maioli M; Tropeano F; Di Vincenzo E; Villani S; Bellandi F
    JACC Cardiovasc Interv; 2014 Dec; 7(12):1421-9. PubMed ID: 25523533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The incidences of organ dysfunction in the early resuscitation of severe sepsis and septic shock patients:a retrospective analysis].
    Wan L; Liao G; Wan X; Huang Y; Huang Q
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2016 May; 28(5):418-22. PubMed ID: 29920036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urine IL-18 is an early diagnostic marker for acute kidney injury and predicts mortality in the intensive care unit.
    Parikh CR; Abraham E; Ancukiewicz M; Edelstein CL
    J Am Soc Nephrol; 2005 Oct; 16(10):3046-52. PubMed ID: 16148039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Renal echography and cystatin C for prediction of acute kidney injury: very different in patients with cardiac failure or sepsis].
    Zhi H; Zhang M; Cui X; Li Y
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2019 Oct; 31(10):1258-1263. PubMed ID: 31771725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence, Outcomes, and Predictors of Subphenotypes of Acute Kidney Injury among Acute Respiratory Distress Syndrome Patients: A Prospective Observational Study.
    Todur P; Nileshwar A; Chaudhuri S; Srinivas T
    Indian J Crit Care Med; 2023 Oct; 27(10):724-731. PubMed ID: 37908431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the preventive efficacy of rosuvastatin versus atorvastatin in post-contrast acute kidney injury in patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention.
    Dai Y; Huang J; Zeng L; Huang Z; Duan C; Shao S; Chen H; Xue L; Chen J; Tan N; He P; Liu Y; Yu D
    Biomed Pharmacother; 2020 Aug; 128():110336. PubMed ID: 32521452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.